ActiQs / Forskning

PUBLIKATIONSREGISTRET

Gå till forskningen.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för dilazep dihydrochloride. Visa hela publikationsregistret

En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publikationer i urvalet

17 träffar

Bibliografisk träff 2005-01-01

Silent cerebral infarction in patients with type 2 diabetic nephropathy. Effects of antiplatelet drug dilazep dihydrochloride.

Nakamura T, Kawagoe Y, Matsuda T, Ueda Y, Ebihara I, Koide H.

Diabetes Metab Res Rev · clinical trial; journal article · DOI 10.1002/dmrr.473

Bibliografisk träff 2002-09-01

Combination AST-120 and dilazep dihydrochloride therapy reduced urinary protein excretion and serum creatinine levels in patients with chronic renal failure.

Nakamura T, Hirokawa K, Matsuda T, Osada S, Takahashi Y, Shimada N, Koide H.

Ren Fail · letter · DOI 10.1081/jdi-120013975

Bibliografisk träff 2002-01-01

Effect of dilazep dihydrochloride on serum cardiac troponin T levels in hemodialysis patients.

Nakamura T, Ushiyama C, Osada S, Ugai K, Takahashi Y, Tanaka A, Shimada N, Ebihara I, Koide H.

Kidney Blood Press Res · clinical trial; randomized controlled trial; journal article · DOI 10.1159/000049435

Bibliografisk träff 2001-05-01

Effect of dilazep dihydrochloride on urinary albumin excretion in patients with autosomal dominant polycystic kidney disease.

Nakamura T, Ushiyama C, Takahashi Y, Tanaka A, Shimada N, Ebihara I, Koide H.

Nephron · clinical trial; journal article · DOI 10.1159/000045963

Bibliografisk träff 2000-08-01

Effect of the antiplatelet drug dilazep dihydrochloride on urinary podocytes in patients in the early stage of diabetic nephropathy.

Nakamura T, Ushiyama C, Shimada N, Sekizuka K, Ebihara I, Hara M, Koide H.

Diabetes Care · controlled clinical trial; clinical trial; multicenter study; journal article · DOI 10.2337/diacare.23.8.1168

Bibliografisk träff 2000-07-01

Effect of dilazep dihydrochloride on plasma P-selectin concentrations in patients with IgA nephropathy.

Ebihara I, Nakamura T, Suzuki S, Ushiyama C, Shimada N, Suzaki M, Koide H.

Nephron · letter · DOI 10.1159/000045675

Bibliografisk träff 2000-01-01

Dilazep dihydrochloride prolongs the infarct size-limiting effect of ischemic preconditioning in rabbits.

Yamasaki K, Tanaka M, Yokota R, Fujiwara H, Sasayama S.

Heart Vessels · journal article · DOI 10.1007/s003800070012

Bibliografisk träff 1995-11-01

Clinical effect of the anti-platelet drug, dilazep dihydrochloride, in patients at the microalbuminuric stage of diabetic nephropathy--a multi-center study.

Koide H, Totsuka Y, Sugisaki T, Kitajima T, Ohmori Y, Kuriyama S, Oi K, Isogai S, Ohi H, Tomino Y.

Nihon Jinzo Gakkai Shi · clinical trial; multicenter study; journal article

Bibliografisk träff 1995-01-01

Effects of antiplatelet drug dilazep dihydrochloride on anionic sites and extracellular matrix (ECM) components in glomerular basement membrane of STZ-induced diabetic rats.

Yamamoto M, Fukui M, Kuramoto T, Kabuki K, Tomino Y.

J Clin Lab Anal · research support, non-u.s. gov't; journal article · DOI 10.1002/jcla.1860090608

Bibliografisk träff 1994-04-01

Effects of an anti-platelet drug (dilazep) in IgA nephropathy: comparison of clinical effects with renal biopsy findings.

Yoshida H, Kanatsu K, Muso E, Kuwahara T, Sekita K, Ono T, Konishi N, Kanda C, Minakata T, Morimoto K.

Nihon Jinzo Gakkai Shi · comparative study; journal article

Bibliografisk träff 1992-04-01

Effect of dilazep dihydrochloride against ischemia and reperfusion-induced disruption of blood-brain barrier in rats: a quantitative study.

Kawagoe J, Abe K, Ikuta J, Igarashi N, Shimizu S, Yamauchi Y, Kogure K.

Naunyn Schmiedebergs Arch Pharmacol · journal article · DOI 10.1007/bf00176629

Bibliografisk träff 1990-05-01

[Effect of dilazep dihydrochloride on ischemia and reperfusion-induced cerebral injury in spontaneously hypertensive rats].

Yamauchi Y, Ikuta J, Shimizu S, Nakamura M.

Nihon Yakurigaku Zasshi · journal article; english abstract · DOI 10.1254/fpj.95.5_239

Bibliografisk träff 1989-04-01

Therapeutic tolerance, hemodynamic effects, and oral dose kinetics of dilazep dihydrochloride in hypertensive patients.

Sambhi MP, Kannan R, Thananopavarn C, Ookhtens M, Gudenzi M.

J Pharm Sci · research support, non-u.s. gov't; research support, u.s. gov't, non-p.h.s.; journal article · DOI 10.1002/jps.2600780404

Bibliografisk träff 1985-09-01

Effects of dilazep dihydrochloride (Dilazep) and its dose-dependent influence on rabbit acute serum sickness nephritis.

Inage H, Koyama A, Narita M, Tojo S.

Nihon Jinzo Gakkai Shi · research support, non-u.s. gov't; journal article

Bibliografisk träff 1985-09-01

Effects of the antiplatelet agents, dipyridamole and dilazep dihydrochloride, on in vivo platelet function and proteinuria.

Inage H, Koyama A, Narita M, Tojo S.

Nihon Jinzo Gakkai Shi · comparative study; research support, non-u.s. gov't; journal article

Bibliografisk träff 1985-05-01

[The effects of dilazep dihydrochloride and vitamin E on P50 in patients with chronic obstructive pulmonary disease].

Nishiura Y.

Nihon Kyobu Shikkan Gakkai Zasshi · research support, non-u.s. gov't; journal article; english abstract

Bibliografisk träff 1983-10-01

[Clinical effects of dilazep dihydrochloride on glomerulonephritis].

Morozumi K, Sohmiya S, Kobayashi M, Sato M, Fujinami T, Yoshida A, Gotoh I.

Nihon Jinzo Gakkai Shi · journal article; english abstract